Telma-MCT 50/12.5 Tablet ER
By Telma-MCT
Rx
10 Tablet ER in a Strip

Composition
Chlorthalidone(12.5mg) + Metoprolol Succinate(50mg) + Telmisartan(40mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
November, 2025

liver
When using Telma-MCT 50/12.5 Tablet ER, it is important to be cautious if you have liver disease. Your doctor may need to adjust your dose to ensure it is safe for you. If you have any concerns about your liver health or if you know you have liver issues, it is essential to consult your doctor before taking Telma-MCT 50/12.5 Tablet ER. It is not advised to use this medication in patients with severe liver disease. Please seek medical advice for proper guidance on the use of Telma-MCT 50/12.5 Tablet ER in case of liver problems.

kidney
Telma-MCT 50/12.5 Tablet ER requires caution in severe kidney disease. Dosage adjustment may be necessary. Avoid usage without consulting your doctor, especially in such cases.

alcohol
It is not safe to drink alcohol while taking Telma-MCT 50/12.5 Tablet ER as it can lead to increased dizziness. It is best to avoid or limit alcohol consumption while using this medication.

driving
When taking Telma-MCT 50/12.5 Tablet ER, be cautious while driving as it can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects. Met XL 3D 50 Tablet 10's can also lead to dizziness, so refrain from driving or operating heavy machinery if feeling dizzy.

pregnancy
During pregnancy, it is important to be cautious with Telma-MCT 50/12.5 Tablet ER as there is evidence of risk to the developing baby. Consult your doctor before use, as it may be prescribed only in life-threatening situations where benefits outweigh potential risks. Discontinue use in the second and third trimesters.

breastfeeding
Telma-MCT 50/12.5 Tablet ER is likely safe during breastfeeding. Limited data indicates low risk to the baby. Consult your doctor to determine if it's suitable for breastfeeding mothers.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹205
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024